Drug Trial Radar · NCT07438405
An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
Last checked: Nov 20, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
May 7, 2026
Primary completion
Jan 29, 2028
Study completion Jul 14, 2028
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Feb 27, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of this trial is to assess the efficacy of AMG 732 in participants with thyroid eye disease (TED) who are defined as primary nonresponders or relapsed during the safety follow-up in the parent trial (NCT06401044).
Conditions
- Thyroid Eye Disease
Interventions
AMG 732Drug
AMG 732 will be administered SC.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants who are Proptosis Responders in the Trial Eye at Week 24 in Participants with TED who are Defined as Primary Nonresponders or Relapsed During the Safety Follow-up in the Parent TrialTime frame: Week 24
Locations
8 sites in 4 countries. Site status is shown where the registry gives one.
Applied Research Center of Arkansas
Little Rock, Arkansas · Recruiting
Ilumina Medical Research
Kissimmee, Florida · Recruiting
Vision Medical Research, Inc.
Orland Park, Illinois · Recruiting
West Virginia University
Morgantown, West Virginia · Recruiting
Eb Group Spolka z ograniczona odpowiedzialnoscia
Warsaw, Poland · Recruiting
Hospital Universitari i Politecnic La Fe
Valencia, Spain · Recruiting
Hospital Universitario Virgen Macarena
Seville, Andalusia, Spain · Recruiting
National Taiwan University Hospital
Taipei, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.